Tran Tuan M, Oliveira-Ferreira Joseli, Moreno Alberto, Santos Fatima, Yazdani Syed S, Chitnis Chetan E, Altman John D, Meyer Esmeralda V-S, Barnwell John W, Galinski Mary R
Emory Vaccine Center & Yerkes National Primate Research Center, Emory University, Atlanta, Georgia 30329, USA.
Am J Trop Med Hyg. 2005 Aug;73(2):244-55.
Naturally acquired antibody reactivity to two major Plasmodium vivax vaccine candidates was investigated in 294 donors from three malaria-endemic communities of Rondônia state, Brazil. Antibody recognition of recombinantly expressed antigens covering five different regions of P. vivax reticulocyte binding protein 1 (PvRBP1) and region II of P. vivax Duffy binding protein (PvDBP-RII) were compared. Positive IgG responses to these antigens were significantly related to the level of malaria exposure in terms of past infections and years of residence in the endemic area when corrected for age. The highest prevalence of anti-PvRBP1 total IgG antibodies corresponded to the amino acid regions denoted PvRBP1(431-748) (41%) and PvRBP1(733-1407) (47%). Approximately one-fifth of positively responding sera had titers of at least 1:1,600. Total IgG responses to PvDBP-RII were more prevalent (67%), of greater magnitude, and acquired more rapidly than those to individual PvRBP1 antigens. Responses to both PvRBP1 and PvDBP-RII were biased toward the cytophilic subclasses IgG1 and IgG3. These data provide the first insights on acquired antibody responses to PvRBP1 and a comparative view with PvDBP-RII that may prove valuable for understanding protective immune responses to these two vaccine candidates as they are evaluated as components of multitarget blood-stage vaccines.
在巴西朗多尼亚州三个疟疾流行社区的294名献血者中,研究了对两种主要间日疟原虫疫苗候选物的自然获得性抗体反应。比较了对覆盖间日疟原虫网织红细胞结合蛋白1(PvRBP1)五个不同区域和间日疟原虫达菲结合蛋白区域II(PvDBP-RII)的重组表达抗原的抗体识别情况。在校正年龄后,针对这些抗原的阳性IgG反应与过去感染和在流行地区居住年限所反映的疟疾暴露水平显著相关。抗PvRBP1总IgG抗体的最高流行率对应于标记为PvRBP1(431 - 748)(41%)和PvRBP1(733 - 1407)(47%)的氨基酸区域。约五分之一呈阳性反应的血清滴度至少为1:1600。对PvDBP-RII的总IgG反应比针对单个PvRBP1抗原的反应更普遍(67%)、强度更大且获得更快。对PvRBP1和PvDBP-RII的反应都偏向嗜细胞亚类IgG1和IgG3。这些数据首次揭示了对PvRBP1的获得性抗体反应,并与PvDBP-RII进行了比较,这对于理解对这两种疫苗候选物的保护性免疫反应可能具有重要价值,因为它们正被评估为多靶点血液阶段疫苗的组成部分。